Investegate announcements from Olink Proteomics AB, Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it contrast to its peers? We will compare Singular Genomics Systems to similar businesses based on the strength of its institutional ownership, valuation, profitability, dividends, earnings, risk and analyst recommendations. Analyst Recommendations This is […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Singular Genomics Systems to similar companies based on the strength of its valuation, institutional ownership, profitability, earnings, risk, analyst recommendations and dividends. Profitability This table compares […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Saturday, Zacks.com reports. The firm currently has a $3.75 price objective on the stock. Zacks Investment Research‘s target price suggests a potential upside of 12.28% from the stock’s […]
Research Analysts’ upgrades for Saturday, June 4th: Agilent Technologies (NYSE:A) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. Amarin (NASDAQ:AMRN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Blucora (NASDAQ:BCOR) was upgraded by analysts at StockNews.com from a hold rating to a buy […]